TriReme Medical Gains $17M In Series D

Pleasanton-based TriReme Medical, a developer of catheter and stent products, said today that it has raised $17M in a Series D funding round. The round was led by Bio*One Capital, and also included current investors Three Arch Partners and Adams Street partners. The firm said the funding will go to ramping up its commercial activities worldwide, as well sa for internal R&D and regulatory approvals. BIo*One Capital is a subsidiary of Singapore's EDB Investments (EDBI). TriReme's devices are being targeted at treatment of coronary and peripheral arterial disease. More information »